Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to' returned 2 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Women's Health Market Strategies - Opportunities remain in this overlooked therapy area   Datamonitor, Oct 2011, Pages: 135 therapy for menopausal symptoms – BZA/CE meets Phase III endpoints and continues its bid to reinvigorate the HRT market Hormonal contraception – potential new bestseller Zoely is approved in the EU Stakeholder Insight: Osteoporosis - Generic Alendronate Further Establishes Oral Bisphosphonates as Gold Standard   Datamonitor, Oct 2008, Pages: 199 Bisphosphonates 90 Bisphosphonate combinations 94 Selective estrogen receptor modulators (SERMs) 96 Parathyroid hormone (PTH) and analogs 98 Calcitonins 100 Dual action bone agents (DABAs) 102 Hormone replacement Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network